Check availabilityExisting-plan tracker · GLP-1
Keep your tirzepatide routine together.
Tirzepatide is a GIP and GLP-1 receptor agonist. The current Zepbound prescribing information reports the timing shown below for that product; your prescribed plan may differ.
Listed injectable brands include Zepbound® and Mounjaro®. Sculpi is not affiliated with their manufacturers.
Reported half-life
About 5–6 days
Reported Tmax
Median 24 h (range 8–72 h)
Label schedule
Once weekly for the listed injectables
A record of the plan you already have.
Sculpi keeps your entered plan, dose history, symptoms and supportive routines together. It does not select a medication, dose, schedule or injection site.
- ✓Reminders you choose, with quiet hours
- ✓A history of the injection sites you record
- ✓User-defined protein, fiber and water targets
- ✓At-home and gym movement logs
Private by design
Your health record is not a marketing profile.
On iOS, app records are stored locally and can sync through the user's private iCloud database. Android records stay local in the current release. Optional connected services remain off until you choose them.
Read the privacy detailsBring a clearer history to your next conversation.
Check app availabilityEducational companion only—not medical advice, diagnosis or treatment. Follow your product label and licensed clinician or pharmacist.